Down's syndrome screening with nuchal translucency at 12(+0)-14(+0) weeks and maternal serum markers at 14(+1)-17(+0) weeks: a prospective study.
Rozenberg P, Malagrida L, Cuckle H, Durand-Zaleski I, Nisand I, Audibert F, Benattar C, Tribalat S, Cartron M, Lemarié P, Stoessel J, Capolagui P, Jansé-Marec J, Barbier D, Allouch C, Perdu M, Roberto A, Lahna Z, Giudicelli Y, Ville Y.
Rozenberg P, et al. Among authors: benattar c.
Hum Reprod. 2002 Apr;17(4):1093-8. doi: 10.1093/humrep/17.4.1093.
Hum Reprod. 2002.
PMID: 11925411